Bio-Techne (TECH) Change in Receivables (2009 - 2026)

Bio-Techne's Change in Receivables history runs 18 years deep, the most recent figure standing at $31.3 million for Q1 2026.

• On a quarterly basis, Change in Receivables rose 99.48% year-over-year to $31.3 million in Q1 2026; TTM through Mar 2026 was -$20.9 million, a 265.5% decrease from a year earlier, with the FY2025 full-year figure at -$34.1 million, down 266.23% from the prior year.
• Change in Receivables climbed to $31.3 million in Q1 2026 per TECH's latest filing, from -$941000.0 in the prior quarter.
• Across five years, Change in Receivables topped out at $51.6 million in Q1 2022 and bottomed at -$28.9 million in Q2 2025.
• The 5-year median for Change in Receivables is $92000.0 (2023), against an average of $3.7 million.
• Across the five-year window, Change in Receivables sank 576.63% in 2022 and surged 19380.43% in 2024, its largest moves.
• Year by year, Change in Receivables stood at $5.9 million in 2022, then slumped by 180.1% to -$4.7 million in 2023, then jumped by 113.16% to $623000.0 in 2024, then tumbled by 251.04% to -$941000.0 in 2025, then soared by 3421.57% to $31.3 million in 2026.
• Per Business Quant, the three latest TECH Change in Receivables figures stand at $31.3 million (Q1 2026), -$941000.0 (Q4 2025), and -$22.4 million (Q3 2025).